Breaking News Instant updates and real-time market news.

UCTT

Ultra Clean

$10.55

-0.11 (-1.03%)

16:06
03/25/19
03/25
16:06
03/25/19
16:06

Ultra Clean names Vijayan Chinnasami as COO

Ultra Clean announced that the company has enhanced its executive team by appointing Vijayan Chinnasami as COO. Chinnasami has spent more than 25 years directing multi-billion-dollar manufacturing operations in the US, Latin America, Europe and Asia. Most recently, Vijay held the role of Senior Vice President, EMS Operations for Jabil Circuit, and prior to that, held similar roles at MEMC, Flextronics and Sony.

  • 28

    May

UCTT Ultra Clean
$10.55

-0.11 (-1.03%)

12/21/18
NEED
12/21/18
INITIATION
Target $13
NEED
Buy
Ultra Clean initiated with a Buy at Needham
Needham analyst N. Quinn Bolton started Ultra Clean with a Buy rating and $13 price target, stating that the company is highly leveraged to the expected recovery in WFE spending in the second half of 2019. He also believes there will be reduced volatility in its business with the recent acquisition of Quantum Global, Bolton tells investors.
02/22/19
CHLM
02/22/19
DOWNGRADE
Target $13
CHLM
Hold
Ultra Clean downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Christian Schwab downgraded Ultra Clean Holdings to Hold from Buy and lowered his price target to $13 from $15 following the company's Q4 results. In a research note to investors, Schwab says with shares up about 50% year to date, he sees limited upside in the near-term until he has better visibility regarding a WFE spending recovery in 2020. Additionally, Schwab says he is also concerned regarding the lack of leverage in the model without a meaningful recovery in WFE given the additional OpEx and cost of debt associated with the Quantum Global acquisition.
03/11/19
CHLM
03/11/19
UPGRADE
Target $13
CHLM
Buy
Ultra Clean upgraded to Buy on valuation at Craig-Hallum
Craig-Hallum analyst Christian Schwab upgraded Ultra Clean to Buy from Hold and established a $13 price target saying the selloff in shares following the Q4 report has created favorable risk/reward. Schwab said a WFE spending recovery remains cloudy, but his estimates are below Street expectations and shares look attractive based on his conservative expectations.
03/21/19
COWN
03/21/19
NO CHANGE
Target $46
COWN
Outperform
Micron controller development unfavorable for Silicon Motion, says Cowen
Cowen analyst Karl Ackerman said Micron's (MU) guidance for the May quarter implies it is still annualizing more money in this downturn than it achieved in the prior peak cycle and that its "materially improved" NAND tech roadmap and expanding growth vectors in DRAM suggest that its free cash flow story is sustainable and underappreciated. However, he said he views Micron's capex read-through as negative for Ichor Holdings (ICHR) and Ultra Clean (UCTT) and he sees the company's controller development as unfavorable for Silicon Motion (SIMO). Ackerman raised his price target on Micron to $46 from $40 and keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

ONTX

Onconova

$0.30

-0.0148 (-4.77%)

07:32
12/06/19
12/06
07:32
12/06/19
07:32
Hot Stocks
Onconova, Inceptua announce Pre-approval Access collaboration for rigosertib »

Onconova Therapeutics and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

07:32
12/06/19
12/06
07:32
12/06/19
07:32
Hot Stocks
Biohaven's troriluzole successfully advances past interim futility analysis »

Biohaven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:30
12/06/19
12/06
07:30
12/06/19
07:30
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRIS

Curis

$1.86

0.045 (2.48%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Hot Stocks
Curis provides updated results from Phase 1 dose escalation study of CA-4948 »

Curis announced updated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

XNCR

Xencor

$40.63

0.05 (0.12%)

07:29
12/06/19
12/06
07:29
12/06/19
07:29
Conference/Events
Xencor to host analyst & investor meeting »

Analyst & Investor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

MRVL

Marvell

$23.44

-0.48 (-2.01%)

07:27
12/06/19
12/06
07:27
12/06/19
07:27
Recommendations
Marvell analyst commentary  »

Marvell price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 06

    Jan

SON

Sonoco

$59.91

-0.04 (-0.07%)

07:25
12/06/19
12/06
07:25
12/06/19
07:25
Conference/Events
Sonoco to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

  • 13

    Dec

RRC

Range Resources

$3.59

0.01 (0.28%)

07:23
12/06/19
12/06
07:23
12/06/19
07:23
Downgrade
Range Resources rating change  »

Range Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MR

Montage Resources

$5.30

0.09 (1.73%)

07:22
12/06/19
12/06
07:22
12/06/19
07:22
Upgrade
Montage Resources rating change  »

Montage Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TGTX

TG Therapeutics

$7.68

-0.51 (-6.23%)

07:19
12/06/19
12/06
07:19
12/06/19
07:19
Conference/Events
TG Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:15
12/06/19
12/06
07:15
12/06/19
07:15
Downgrade
Sage Therapeutics rating change  »

Sage Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQST

Aquestive Therapeutics

$8.36

-0.42 (-4.78%)

07:15
12/06/19
12/06
07:15
12/06/19
07:15
Conference/Events
Aquestive Therapeutics to host investor & analyst meeting »

Investor & Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

OKTA

Okta

$119.18

-2.64 (-2.17%)

07:13
12/06/19
12/06
07:13
12/06/19
07:13
Recommendations
Okta analyst commentary  »

Okta price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

PHG

Philips

07:13
12/06/19
12/06
07:13
12/06/19
07:13
Upgrade
Philips rating change  »

Morgan Stanley upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

07:10
12/06/19
12/06
07:10
12/06/19
07:10
Recommendations
Sage Therapeutics analyst commentary  »

Sage Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNST

Constellation Pharmaceuticals

$42.66

-3.34 (-7.26%)

07:08
12/06/19
12/06
07:08
12/06/19
07:08
Conference/Events
Constellation Pharmaceuticals to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 09

    Dec

PBYI

Puma Biotechnology

$7.43

-1.52 (-16.98%)

07:07
12/06/19
12/06
07:07
12/06/19
07:07
Initiation
Puma Biotechnology initiated  »

Puma Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.94

0.17 (0.54%)

07:06
12/06/19
12/06
07:06
12/06/19
07:06
Initiation
MGM Resorts initiated  »

MGM Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$119.18

-2.64 (-2.17%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Recommendations
Okta analyst commentary  »

Okta traction in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

RCKT

Rocket Pharmaceuticals

$19.76

0.54 (2.81%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Hot Stocks
Rocket Pharmaceuticals announces first patient treated in Phase 2 RP-L102 study »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 08

    Dec

UCBJY

UCB

$0.00

(0.00%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Hot Stocks
UCB: Phase 3 BE SURE results met co-primary, ranked secondary endpoints »

UCB announced positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLG

SL Green Realty

$85.75

-0.08 (-0.09%)

07:05
12/06/19
12/06
07:05
12/06/19
07:05
Conference/Events
SL Green Realty to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

TELA

Tela Bio

$12.11

-1.09 (-8.26%)

07:04
12/06/19
12/06
07:04
12/06/19
07:04
Hot Stocks
Tela Bio awarded contract with HealthTrust Purchasing Group »

TELA Bio announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

07:03
12/06/19
12/06
07:03
12/06/19
07:03
Recommendations
Ulta Beauty analyst commentary  »

Ulta Beauty results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

APLT

Applied Therapeutics

$21.78

-2.56 (-10.52%)

07:02
12/06/19
12/06
07:02
12/06/19
07:02
Hot Stocks
Applied Therapeutics to present pre-clinical data highlighting AT-001 »

Applied Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.